Cargando…
A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
Background: Pulmonary emboli (PE) represents an extended spectrum of diseases. 10% of submassive PE progress to massive PE, and while overall mortality is around 5%, it can reach 30%,(1) highlighting the potential severity of submassive PE. Treatment of low and high-risk PE is rather straightforward...
Autor principal: | Seif, Mohamed Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HBKU Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978766/ http://dx.doi.org/10.5339/qmj.2019.qccc.80 |
Ejemplares similares
-
Intermediate pulmonary embolism: Diagnosis and management
por: Davidson, Bruce L
Publicado: (2019) -
SUBMASSIVE PULMONARY EMBOLISM IN COVID-19 INFECTION: TRUE INCIDENCE OR COINCIDENCE?
por: Hopson, Roger, et al.
Publicado: (2020) -
Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021) -
Role of the intensivist for organ donation
por: Rohrig, Stefan Alfred Hubertus
Publicado: (2019) -
DVT prophylaxis in critical care: role of NOACS
por: Lancé, Marcus D.
Publicado: (2019)